Real-World Evidence Generation and Evaluation of Therapeutics
Work detail
Bookitis PickRE
Real-World Evidence Generation and Evaluation of Therapeutics
Board on Health Sciences PolicyNational Academies of Sciences, Engineering, and MedicineHealth and Medicine DivisionForum on Drug Discovery, Development, and TranslationAnne B. Claiborne4 editions
This page groups all known editions belonging to the same underlying work.
Overview
Shared work-level identity and catalog context.
5 credited authorsSearch language english
Contributors
People credited with this work in the active catalog.
- Open Author
Board on Health Sciences Policy
- Open Author
National Academies of Sciences, Engineering, and Medicine
- Open Author
Health and Medicine Division
- Open Author
Forum on Drug Discovery, Development, and Translation
- Open Author
Anne B. Claiborne
Editions
Publication-specific versions linked to this work only.
- REReal-World Evidence Generation...National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Forum on Drug Discovery, Development, and Translation, Anne B. Claiborne
Real-World Evidence Generation and Evaluation of Therapeutics
- REReal-World Evidence Generation...National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Forum on Drug Discovery, Development, and Translation, Anne B. Claiborne
Real-World Evidence Generation and Evaluation of Therapeutics
- REReal-World Evidence Generation...National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Forum on Drug Discovery, Development, and Translation, Anne B. Claiborne
Real-World Evidence Generation and Evaluation of Therapeutics
- REReal-World Evidence Generation...National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Forum on Drug Discovery, Development, and Translation, Anne B. Claiborne
Real-World Evidence Generation and Evaluation of Therapeutics